Vestcor Inc lowered its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 2.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,248 shares of the company’s stock after selling 103 shares during the period. Vestcor Inc’s holdings in Chemed were worth $2,251,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of CHE. UMB Bank n.a. grew its position in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Trust Co. of Vermont purchased a new position in Chemed in the fourth quarter worth $34,000. Tortoise Investment Management LLC increased its position in shares of Chemed by 77.3% during the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock worth $41,000 after purchasing an additional 34 shares in the last quarter. SRS Capital Advisors Inc. lifted its holdings in shares of Chemed by 39.2% during the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company’s stock valued at $72,000 after purchasing an additional 38 shares during the last quarter. Finally, Allworth Financial LP boosted its position in shares of Chemed by 2,057.1% in the 4th quarter. Allworth Financial LP now owns 151 shares of the company’s stock worth $83,000 after purchasing an additional 144 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.
Insider Transactions at Chemed
In other Chemed news, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company’s stock.
Chemed Price Performance
Chemed Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio is presently 10.05%.
Analyst Upgrades and Downgrades
CHE has been the topic of several recent analyst reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Royal Bank of Canada increased their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research report on Friday.
View Our Latest Analysis on CHE
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
- Five stocks we like better than Chemed
- How to Profit From Growth Investing
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Investing in the High PE Growth Stocks
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.